{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:58:58Z","timestamp":1781647138897,"version":"3.54.5"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Laboratoire Innotech International"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      In Africa, vulvovaginal infections represent a public health issue due to their frequency and complications. Recent studies have shown a significant shift in bacterial ecology, which is increasingly dominated by bacterial vaginosis. The PETAL study aimed to determine the epidemiological, clinical, and microbiological profile of vulvovaginal infections in Dakar (Senegal), to assess the predictive etiological value of the syndromic approach by comparing it with microbiological results, and to evaluate the clinical and microbiological efficacy and the tolerance of treating bacterial vaginosis with the Neomycin-Polymyxin B-Nystatin (NNP) combination (Polygynax\n                      <jats:sup>\u00ae<\/jats:sup>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This monocentric, prospective, single-arm and observational study was conducted at the Gynecology-Obstetrics Department of Institut d\u2019Hygi\u00e8ne Social Hospital in Dakar. Women with suspected vulvovaginal infection underwent a clinical exam and vaginal bacteriological sampling. Based on the WHO syndromic approach, an initial diagnosis was made, and patients received NNP treatment (one vaginal capsule daily for 12 days). Clinical and microbiological outcomes were assessed on Day 15 after treatment. Consistency between the syndromic and microbiological diagnoses was evaluated using Cohen\u2019s Kappa test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Women included in this study were on average 32 years old, mostly married (87.0%) and unemployed (52.2%). Among the 224 patients analyzed, 78.6% had positive bacteriological results at Day 0. Bacterial vaginosis was confirmed in 68.7% of cases, either alone (44.6%) or associated with candidiasis (22.8%) or trichomoniasis (1.3%). Isolated candidiasis accounted for 9.8%. High mixed-infection rates highlight diagnostic challenges. The syndromic approach showed strong consistency with microbiological diagnosis for bacterial vaginosis (sensitivity: 100%; specificity: 96.1%), but lower agreement for candidiasis (sensitivity: 100%; specificity: 78%) and mixed infections (sensitivity: 59.3%; specificity: 100%). Clinical remission was achieved in 91.4% of cases and bacteriological cure in 73.3% of vaginosis cases. The treatment was well tolerated (98.5%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Vulvovaginal infections in Dakar are largely dominated by bacterial vaginosis. In cases of isolated vaginosis, the syndromic approach showed very good consistency with the bacteriological diagnosis, while it seems less suitable for identifying mixed infections, which account for one-third of cases. In this context, the NNP combination could be an appropriate, effective, and well-tolerated treatment for the management of bacterial vaginosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12905-026-04443-w","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:33:18Z","timestamp":1775694798000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epidemiology and management of bacterial vaginosis in Dakar, Senegal"],"prefix":"10.1186","volume":"26","author":[{"given":"Cheikh A.T.","family":"Ciss\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouhamadou M.","family":"Niang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Escola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4285-0519","authenticated-orcid":false,"given":"Barbara","family":"Quioc-Salomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte P.J.","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Carrois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"issue":"1","key":"4443_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1471-0528.2002.00432.x","volume":"109","author":"GGG Donders","year":"2002","unstructured":"Donders GGG, Vereecken A, Bosmans E, Dekeersmaecker A, Salembier G, Spitz B. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. BJOG: Intern J Obs Gyn janv. 2002;109(1):34\u201343. https:\/\/doi.org\/10.1111\/j.1471-0528.2002.00432.x.","journal-title":"BJOG: Intern J Obs Gyn janv"},{"key":"4443_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ejogrb.2019.12.035","volume":"245","author":"MS Coudray","year":"2020","unstructured":"Coudray MS, Madhivanan P. Bacterial vaginosis\u2014A brief synopsis of the literature. Eur J Obstet Gynecol Reproductive Biology f\u00e9vr. 2020;245:143\u20138. https:\/\/doi.org\/10.1016\/j.ejogrb.2019.12.035.","journal-title":"Eur J Obstet Gynecol Reproductive Biology f\u00e9vr"},{"issue":"1","key":"4443_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40779-016-0074-5","volume":"3","author":"CT Bautista","year":"2016","unstructured":"Bautista CT, Wurapa E, Sateren WB, Morris S, Hollingsworth B, Sanchez JL. Bacterial vaginosis: a synthesis of the literature on etiology, prevalence, risk factors, and relationship with chlamydia and gonorrhea infections. Military Med Res d\u00e9c. 2016;3(1):4. https:\/\/doi.org\/10.1186\/s40779-016-0074-5.","journal-title":"Military Med Res d\u00e9c"},{"key":"4443_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1471-2334-5-12","volume":"5","author":"E Demba","year":"2005","unstructured":"Demba E, Morison L, van der Loeff MS, Awasana AA, Gooding E, Bailey R, et al. Bacterial vaginosis, vaginal flora patterns and vaginal hygiene practices in patients presenting with vaginal discharge syndrome in The Gambia, West Africa. BMC Infect Dis 9 mars. 2005;5:12. https:\/\/doi.org\/10.1186\/1471-2334-5-12. PubMed PMID: 15757510; PubMed Central PMCID: PMC1083415.","journal-title":"BMC Infect Dis 9 mars"},{"issue":"5","key":"4443_CR5","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/tmi.13046","volume":"23","author":"MS Barry","year":"2018","unstructured":"Barry MS, Ba Diallo A, Diadhiou M, Mall I, Gassama O, Ndiaye Gu\u00e8ye MD, et al. Accuracy of syndromic management in targeting vaginal and cervical infections among symptomatic women of reproductive age attending primary care clinics in Dakar, Senegal. Tropical Med Int Health. 2018;23(5):541\u20138. https:\/\/doi.org\/10.1111\/tmi.13046.","journal-title":"Tropical Med Int Health"},{"issue":"10","key":"4443_CR6","doi-asserted-by":"publisher","first-page":"e109670","DOI":"10.1371\/journal.pone.0109670","volume":"9","author":"V Jespers","year":"2014","unstructured":"Jespers V, Crucitti T, Menten J, Verhelst R, Mwaura M, Mandaliya K, et al. Prevalence and Correlates of Bacterial Vaginosis in Different Sub-Populations of Women in Sub-Saharan Africa: A Cross-Sectional Study. PLOS ONE 7 oct. 2014;9(10):e109670. https:\/\/doi.org\/10.1371\/journal.pone.0109670.","journal-title":"PLOS ONE 7 oct"},{"issue":"9","key":"4443_CR7","doi-asserted-by":"publisher","first-page":"e25082","DOI":"10.1371\/journal.pone.0025082","volume":"6","author":"J P\u00e9pin","year":"2011","unstructured":"P\u00e9pin J, Deslandes S, Giroux G, Sob\u00e9la F, Khonde N, Diakit\u00e9 S, et al. The complex vaginal flora of West African women with bacterial vaginosis. PLoS ONE. 2011;6(9):e25082. https:\/\/doi.org\/10.1371\/journal.pone.0025082. PubMed PMID: 21949860; PubMed Central PMCID: PMC3176826.","journal-title":"PLoS ONE"},{"issue":"1","key":"4443_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12884-025-07144-8","volume":"25","author":"N Sethi","year":"2025","unstructured":"Sethi N, Narayanan V, Saaid R, Ahmad Adlan AS, Ngoi ST, Teh CSJ, et al. Prevalence, risk factors, and adverse outcomes of bacterial vaginosis among pregnant women: a systematic review. BMC Pregnancy Childbirth 20 janv. 2025;25(1):40. https:\/\/doi.org\/10.1186\/s12884-025-07144-8. PubMed PMID: 39833700; PubMed Central PMCID: PMC11744995.","journal-title":"BMC Pregnancy Childbirth 20 janv"},{"key":"4443_CR9","doi-asserted-by":"publisher","first-page":"97424","DOI":"10.1155\/2007\/97424","volume":"2007","author":"LB Angotti","year":"2007","unstructured":"Angotti LB, Lambert LC, Soper DE. Vaginitis: making sense of over-the-counter treatment options. Infect Dis Obstet Gynecol. 2007;2007:97424. doi:10.1155\/2007\/97424 PubMed PMID: 18253469; PubMed Central PMCID: PMC1986759.","journal-title":"Infect Dis Obstet Gynecol"},{"key":"4443_CR10","unstructured":"Paladine HL, Desai UA, Vaginitis. Diagnosis and Treatment. Am Fam Physician. 1 mars 2018;97(5):321\u20139. PubMed PMID: 29671516."},{"key":"4443_CR11","unstructured":"World Health Organization. Guidelines for the management of symptomatic sexually transmitted infections. Geneva: World Health Organization; 2021. p. 45\u201358. PubMed PMID: 34370424. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK572659\/."},{"key":"4443_CR12","doi-asserted-by":"publisher","unstructured":"Bohbot JM, Brami G, Goubard A, Harvey T. La vaginose bact\u00e9rienne en 10 questions. Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie. 2020;48(9):693\u2013702. https:\/\/doi.org\/10.1016\/j.gofs.2020.05.003.","DOI":"10.1016\/j.gofs.2020.05.003"},{"key":"4443_CR13","doi-asserted-by":"publisher","first-page":"672429","DOI":"10.3389\/fcimb","volume":"11","author":"L Abou Chacra","year":"2022","unstructured":"Abou Chacra L, Fenollar F, Diop K. Bacterial Vaginosis: What Do We Currently Know? Front Cell Infect Microbiol 18 janv. 2022;11:672429. https:\/\/doi.org\/10.3389\/fcimb. 2021.672429 PubMed PMID: 35118003; PubMed Central PMCID: PMC8805710.","journal-title":"Front Cell Infect Microbiol 18 janv"},{"issue":"3","key":"4443_CR14","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S1701-2163(15)30316-9","volume":"37","author":"J Van Schalkwyk","year":"2015","unstructured":"Van Schalkwyk J, Yudin MH, Yudin MH, Allen V, Bouchard C, Boucher M, et al. Vulvovaginitis: Screening for and Management of Trichomoniasis, Vulvovaginal Candidiasis, and Bacterial Vaginosis. J Obstet Gynecol Can mars. 2015;37(3):266\u201374. https:\/\/doi.org\/10.1016\/S1701-2163(15)30316-9.","journal-title":"J Obstet Gynecol Can mars"},{"key":"4443_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2010\/705692","volume":"2010","author":"JM Bohbot","year":"2010","unstructured":"Bohbot JM, Vicaut E, Fagnen D, Brauman M. Treatment of Bacterial Vaginosis: A Multicenter, Double-Blind, Double-Dummy, Randomised Phase III Study Comparing Secnidazole and Metronidazole. Infect Dis Obstet Gynecol. 2010;2010:1\u20136. https:\/\/doi.org\/10.1155\/2010\/705692.","journal-title":"Infect Dis Obstet Gynecol"},{"issue":"13","key":"4443_CR16","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1177\/0956462418785451","volume":"29","author":"J Sherrard","year":"2018","unstructured":"Sherrard J, Wilson J, Donders G, Mendling W, Jensen JS. 2018 European (IUSTI\/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge. Int J STD AIDS nov. 2018;29(13):1258\u201372. https:\/\/doi.org\/10.1177\/0956462418785451.","journal-title":"Int J STD AIDS nov"},{"issue":"3","key":"4443_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/ph18030340","volume":"18","author":"C Feuillolay","year":"2025","unstructured":"Feuillolay C, Salvatico S, Escola J, Quioc-Salomon B, Carrois F, Roques C. In Vitro Bactericidal Activity of a Neomycin-Polymyxin B-Nystatin Combination Compared to Metronidazole and Clindamycin Against the Main Bacteria Involved in Bacterial Vaginosis and Aerobic Vaginitis. Pharmaceuticals mars. 2025;18(3):3. https:\/\/doi.org\/10.3390\/ph18030340.","journal-title":"Pharmaceuticals mars"},{"key":"4443_CR18","doi-asserted-by":"publisher","unstructured":"Oduyebo OO, Anorlu RI, Ogunsola FT. The effects of antimicrobial therapy on bacterial vaginosis in non-pregnant women. Cochrane Database Syst Rev 8 juill. 2009;3CD006055. https:\/\/doi.org\/10.1002\/14651858.CD006055.pub2. PubMed PMID: 19588379.","DOI":"10.1002\/14651858.CD006055.pub2"},{"issue":"6","key":"4443_CR19","first-page":"678","volume":"217","author":"JR Schwebke","year":"2017","unstructured":"Schwebke JR, Morgan FG, Koltun W, Nyirjesy P. A phase-3, double-blind, placebo-controlled study of the effectiveness and safety of single oral doses of secnidazole 2\u00a0g for the treatment of women with bacterial vaginosis. Am J Obstet Gynecol d\u00e9c. 2017;217(6):678. .e1-678.e9. .017 PubMed PMID: 28867602.","journal-title":"Am J Obstet Gynecol d\u00e9c"},{"issue":"1","key":"4443_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00404-019-05142-8","volume":"300","author":"W Mendling","year":"2019","unstructured":"Mendling W, Palmeira-de-Oliveira A, Biber S, Prasauskas V. An update on the role of Atopobium vaginae in bacterial vaginosis: what to consider when choosing a treatment? A mini review. Arch Gynecol Obstet juill. 2019;300(1):1\u20136. https:\/\/doi.org\/10.1007\/s00404-019-05142-8.","journal-title":"Arch Gynecol Obstet juill"},{"issue":"suppl1","key":"4443_CR21","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1093\/infdis\/jiw159","volume":"214","author":"CS Bradshaw","year":"2016","unstructured":"Bradshaw CS, Sobel JD. Current Treatment of Bacterial Vaginosis\u2014Limitations and Need for Innovation. J Infect Dis 15 ao\u00fbt. 2016;214(suppl1):S14\u201320. https:\/\/doi.org\/10.1093\/infdis\/jiw159.","journal-title":"J Infect Dis 15 ao\u00fbt"},{"issue":"9","key":"4443_CR22","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1093\/cid\/ciaa260","volume":"72","author":"SL Hillier","year":"2021","unstructured":"Hillier SL, Austin M, Macio I, Meyn LA, Badway D, Beigi R. Diagnosis and Treatment of Vaginal Discharge Syndromes in Community Practice Settings. Clin Infect Dis 4 mai. 2021;72(9):1538\u201343. https:\/\/doi.org\/10.1093\/cid\/ciaa260.","journal-title":"Clin Infect Dis 4 mai"},{"key":"4443_CR23","doi-asserted-by":"publisher","unstructured":"Bohbot JM, Sednaoui P, Verriere F, Achhammer I. oct. Diversit\u00e9 \u00e9tiologique des vaginites. Gyn\u00e9cologie Obst\u00e9trique & Fertilit\u00e9. 1 2012;40(10):578\u201381. https:\/\/doi.org\/10.1016\/j.gyobfe.2011.08.001","DOI":"10.1016\/j.gyobfe.2011.08.001"},{"issue":"3","key":"4443_CR24","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.medmal.2019.01.011","volume":"49","author":"JM Bohbot","year":"2019","unstructured":"Bohbot JM, Goubard A, Aubin F, Mas Y, Coatantiec E, Lucas N, et al. PRISM study: Comparison of a nystatin-neomycin-polymyxin B combination with miconazole for the empirical treatment of infectious vaginitis. M\u00e9decine et Maladies Infectieuses 1 mai. 2019;49(3):194\u2013201. https:\/\/doi.org\/10.1016\/j.medmal.2019.01.011.","journal-title":"M\u00e9decine et Maladies Infectieuses 1 mai"},{"issue":"2","key":"4443_CR25","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1128\/jcm.29.2.297-301","volume":"29","author":"RP Nugent","year":"1991","unstructured":"Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol f\u00e9vr. 1991;29(2):297\u2013301. https:\/\/doi.org\/10.1128\/jcm.29.2.297-301. 1991 PubMed PMID: 1706728; PubMed Central PMCID: PMC269757.","journal-title":"J Clin Microbiol f\u00e9vr"},{"issue":"1","key":"4443_CR26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/0002-9343","volume":"74","author":"R Amsel","year":"1983","unstructured":"Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med janv. 1983;74(1):14\u201322. https:\/\/doi.org\/10.1016\/0002-9343. )91112-9 PubMed PMID: 6600371.","journal-title":"Am J Med janv"},{"issue":"1","key":"4443_CR27","doi-asserted-by":"publisher","first-page":"9813","DOI":"10.1038\/s41598-024-58654-y","volume":"14","author":"A Aklilu","year":"2024","unstructured":"Aklilu A, Woldemariam M, Manilal A, Koira G, Alahmadi RM, Raman G, et al. Aerobic vaginitis, bacterial vaginosis, and vaginal candidiasis among women of reproductive age in Arba Minch, southern Ethiopia. Sci Rep 29 avr. 2024;14(1):9813. https:\/\/doi.org\/10.1038\/s41598-024-58654-y.","journal-title":"Sci Rep 29 avr"},{"issue":"3","key":"4443_CR28","doi-asserted-by":"publisher","first-page":"147","DOI":"10.4103\/0970-258X.278691","volume":"32","author":"V Gupta","year":"2019","unstructured":"Gupta V, Sharma V. Syndromic management of sexually transmitted infections: A critical appraisal and the road ahead. Natl Med J India. 2019;32(3):147. https:\/\/doi.org\/10.4103\/0970-258X.278691.","journal-title":"Natl Med J India"},{"issue":"10","key":"4443_CR29","doi-asserted-by":"publisher","first-page":"e0163365","DOI":"10.1371\/journal.pone.0163365","volume":"11","author":"C Zemouri","year":"2016","unstructured":"Zemouri C, Wi TE, Kiarie J, Seuc A, Mogasale V, Latif A, et al. The Performance of the Vaginal Discharge Syndromic Management in Treating Vaginal and Cervical Infection: A Systematic Review and Meta-Analysis. Schmidt RL, \u00e9diteur. PLoS ONE 5 oct. 2016;11(10):e0163365. https:\/\/doi.org\/10.1371\/journal.pone.0163365.","journal-title":"PLoS ONE 5 oct"},{"issue":"2","key":"4443_CR30","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/01.AOG.0000134783.98382.b0","volume":"104","author":"MA Klebanoff","year":"2004","unstructured":"Klebanoff MA, Schwebke JR, Zhang J, Nansel TR, Yu KF, Andrews WW. Vulvovaginal symptoms in women with bacterial vaginosis. Obstet Gynecol ao\u00fbt. 2004;104(2):267\u201372. https:\/\/doi.org\/10.1097\/01.AOG.0000134783.98382.b0. PubMed PMID: 15291998.","journal-title":"Obstet Gynecol ao\u00fbt"},{"key":"4443_CR31","unstructured":"Myrhaug HT, Brurberg KG, Kirkehei I, Reinar LM, the Health Services at The Norwegian Institute of Public Health (NIPH). Treatment of Pregnant Women with Asymptomatic Bacterial Vaginosis with Clindamycin. Oslo, Norway: Knowledge Centre for ; 2010. (NIPH Systematic Reviews: Executive Summaries). Disponible sur: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK464813\/ PubMed PMID: 29320035.\u00a0 [Cit\u00e9 5 ao\u00fbt 2025]."},{"issue":"7","key":"4443_CR32","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1111\/j.1365-2702.2008","volume":"18","author":"S Kisa","year":"2009","unstructured":"Kisa S, Taskin L. Validity of the symptomatic approach used by nurses in diagnosing vaginal infections. J Clin Nurs avr. 2009;18(7):1059\u201368. https:\/\/doi.org\/10.1111\/j.1365-2702.2008. 02702.x PubMed PMID: 19284438.","journal-title":"J Clin Nurs avr"},{"issue":"4","key":"4443_CR33","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S0399-077X(03)00018-0","volume":"33","author":"A Boisivon","year":"2003","unstructured":"Boisivon A, Berard H, Nandeuil A, Cheron M, Lafon J, Fabayre C. Diagnostic des vaginites en m\u00e9decine g\u00e9n\u00e9rale: confrontation clinique et bact\u00e9riologique. M\u00e9decine et Maladies Infectieuses 1 avr. 2003;33(4):202\u20135. https:\/\/doi.org\/10.1016\/S0399-077X(03)00018-0.","journal-title":"M\u00e9decine et Maladies Infectieuses 1 avr"},{"issue":"6","key":"4443_CR34","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ajog.2013.05.006","volume":"209","author":"C Kenyon","year":"2013","unstructured":"Kenyon C, Colebunders R, Crucitti T. The global epidemiology of bacterial vaginosis: a systematic review. Am J Obstet Gynecol d\u00e9c. 2013;209(6):505\u201323. https:\/\/doi.org\/10.1016\/j.ajog.2013.05.006. PubMed PMID: 23659989.","journal-title":"Am J Obstet Gynecol d\u00e9c"},{"issue":"5","key":"4443_CR35","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/OLQ.0000000000000972","volume":"46","author":"K Peebles","year":"2019","unstructured":"Peebles K, Velloza J, Balkus JE, McClelland RS, Barnabas RV. High Global Burden and Costs of Bacterial Vaginosis: A Systematic Review and Meta-Analysis. Sex Transm Dis mai. 2019;46(5):304\u201311. 10. 1097\/OLQ.0000000000000972 PubMed PMID: 30624309.","journal-title":"Sex Transm Dis mai"},{"issue":"supplement1","key":"4443_CR36","doi-asserted-by":"publisher","first-page":"4680","DOI":"10.1073\/pnas.1002611107","volume":"108","author":"J Ravel","year":"2011","unstructured":"Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SSK, McCulle SL, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci USA 15 mars. 2011;108(supplement1):4680\u20137. https:\/\/doi.org\/10.1073\/pnas.1002611107.","journal-title":"Proc Natl Acad Sci USA 15 mars"},{"key":"4443_CR37","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.24072\/pcjournal.527","volume":"5","author":"T Kamiya","year":"2025","unstructured":"Kamiya T, Tessandier N, Elie B, Bernat C, Bou\u00e9 V, Grasset S, et al. Factors shaping vaginal microbiota long-term community dynamics in young adult women. Peer Community J 12 mars. 2025;5:e30. https:\/\/doi.org\/10.24072\/pcjournal.527.","journal-title":"Peer Community J 12 mars"},{"issue":"5","key":"4443_CR38","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.socscimed.2008.05.017","volume":"67","author":"K Paul","year":"2008","unstructured":"Paul K, Boutain D, Manhart L, Hitti J. Racial disparity in bacterial vaginosis: the role of socioeconomic status, psychosocial stress, and neighborhood characteristics, and possible implications for preterm birth. Soc Sci Med sept. 2008;67(5):824\u201333. https:\/\/doi.org\/10.1016\/j.socscimed.2008.05.017. PubMed PMID: 18573578.","journal-title":"Soc Sci Med sept"},{"key":"4443_CR39","unstructured":"Minist\u00e8re, Economie. Plan et Coop\u00e9ration. Recensement General De La Population Et De L\u2019habitat, 2023 (Rgph-5, 2023), Dakar, Juillet 2024). 2024. Disponible sur: chrome-chrome-extension:\/\/efaidnbmnnnibpcajpcglclefindmkaj\/https:\/\/www.ansd.sn\/sites\/default\/files\/2024-07\/RGPH-5_Rapport%20global-Prov-juillet2024.pdf."},{"issue":"3","key":"4443_CR40","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0020-7292(00)00217-4","volume":"70","author":"E Calzolari","year":"2000","unstructured":"Calzolari E, Masciangelo R, Milite V, Verteramo R. Bacterial vaginosis and contraceptive methods. Int J Gynecol Obstet. 2000;70(3):341\u20136. https:\/\/doi.org\/10.1016\/S0020-7292(00)00217-4.","journal-title":"Int J Gynecol Obstet"},{"key":"4443_CR41","doi-asserted-by":"publisher","unstructured":"Bakus C, Budge KL, Feigenblum N, Figueroa M, Francis AP. The impact of contraceptives on the vaginal microbiome in the non-pregnant state. Front Microbiomes 30 janv. 2023;1. https:\/\/doi.org\/10.3389\/frmbi.2022.1055472.","DOI":"10.3389\/frmbi.2022.1055472"},{"issue":"10160","key":"4443_CR42","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1016\/S0140-6736","volume":"392","author":"D Subtil","year":"2018","unstructured":"Subtil D, Brabant G, Tilloy E, Devos P, Canis F, Fruchart A, et al. Early clindamycin for bacterial vaginosis in pregnancy (PREMEVA): a multicentre, double-blind, randomised controlled trial. Lancet 17 nov. 2018;392(10160):2171\u20139. https:\/\/doi.org\/10.1016\/S0140-6736. (18)31617-9 PubMed PMID: 30322724.","journal-title":"Lancet 17 nov"},{"issue":"2","key":"4443_CR43","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/1471-0528","volume":"126","author":"T Haahr","year":"2019","unstructured":"Haahr T, Zacho J, Br\u00e4uner M, Shathmigha K, Skov Jensen J, Humaidan P. Reproductive outcome of patients undergoing in vitro fertilisation treatment and diagnosed with bacterial vaginosis or abnormal vaginal microbiota: a systematic PRISMA review and meta-analysis. BJOG janv. 2019;126(2):200\u20137. https:\/\/doi.org\/10.1111\/1471-0528. .15178 PubMed PMID: 29469992.","journal-title":"BJOG janv"},{"key":"4443_CR44","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1146\/annurev-micro","volume":"66","author":"B Ma","year":"2012","unstructured":"Ma B, Forney LJ, Ravel J. The vaginal microbiome: rethinking health and diseases. Annu Rev Microbiol. 2012;66:371\u201389. https:\/\/doi.org\/10.1146\/annurev-micro. -092611-150157 PubMed PMID: 22746335; PubMed Central PMCID: PMC3780402.","journal-title":"Annu Rev Microbiol"},{"issue":"Suppl 10","key":"4443_CR45","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1186\/s12864-018-5284-7","volume":"19","author":"HM Chen","year":"2018","unstructured":"Chen HM, Chang TH, Lin FM, Liang C, Chiu CM, Yang TL, et al. Vaginal microbiome variances in sample groups categorized by clinical criteria of bacterial vaginosis. BMC Genomics 31 d\u00e9c. 2018;19(Suppl 10):876. https:\/\/doi.org\/10.1186\/s12864-018-5284-7. PubMed PMID: 30598080; PubMed Central PMCID: PMC6311936.","journal-title":"BMC Genomics 31 d\u00e9c"},{"issue":"2","key":"4443_CR46","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1128\/CMR.00075-15","volume":"29","author":"AB Onderdonk","year":"2016","unstructured":"Onderdonk AB, Delaney ML, Fichorova RN. The Human Microbiome during Bacterial Vaginosis. Clin Microbiol Rev avr. 2016;29(2):223\u201338. 10. 1128\/CMR.00075-15 PubMed PMID: 26864580; PubMed Central PMCID: PMC4786887.","journal-title":"Clin Microbiol Rev avr"},{"issue":"5","key":"4443_CR47","doi-asserted-by":"publisher","first-page":"e248661","DOI":"10.1001\/jamanetworkopen.2024.8661","volume":"7","author":"G Raba","year":"2024","unstructured":"Raba G, \u010eurkech A, Mal\u00edk T, Bassfeld D, Grob P, Hurtado-Chong A, et al. Efficacy of Dequalinium Chloride vs Metronidazole for the Treatment of Bacterial Vaginosis: A Randomized Clinical Trial. JAMA Netw Open 1 mai. 2024;7(5):e248661\u2013248661. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.8661.","journal-title":"JAMA Netw Open 1 mai"},{"key":"4443_CR48","doi-asserted-by":"publisher","unstructured":"Vodstrcil LA, Plummer EL, Fairley CK, Hocking JS, Law MG, Petoumenos K et al. Male-Partner Treatment to Prevent Recurrence of Bacterial Vaginosis. N Engl J Med. 2025;392(10):947\u201357. https:\/\/doi.org\/10.1056\/NEJMoa2405404. PubMed PMID: 40043236.","DOI":"10.1056\/NEJMoa2405404"},{"issue":"2","key":"4443_CR49","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jogoh.2017.11.005","volume":"47","author":"JM Bohbot","year":"2018","unstructured":"Bohbot JM, Dara\u00ef E, Bretelle F, Brami G, Daniel C, Cardot JM. Efficacy and safety of vaginally administered lyophilized Lactobacillus crispatus IP 174178 in the prevention of bacterial vaginosis recurrence. J Gynecol Obstet Hum Reprod f\u00e9vr. 2018;47(2):81\u20136. .005 PubMed PMID: 29196153.","journal-title":"J Gynecol Obstet Hum Reprod f\u00e9vr"},{"issue":"2","key":"4443_CR50","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ajog.2021.09.018","volume":"226","author":"AT Gustin","year":"2022","unstructured":"Gustin AT, Thurman AR, Chandra N, Schifanella L, Alcaide M, Fichorova R, et al. Recurrent bacterial vaginosis following metronidazole treatment is associated with microbiota richness at diagnosis. Am J Obstet Gynecol f\u00e9vr. 2022;226(2):225. https:\/\/doi.org\/10.1016\/j.ajog.2021.09.018.","journal-title":"Am J Obstet Gynecol f\u00e9vr"},{"issue":"20","key":"4443_CR51","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1056\/NEJMoa1915254","volume":"382","author":"CR Cohen","year":"2020","unstructured":"Cohen CR, Wierzbicki MR, French AL, Morris S, Newmann S, Reno H, et al. Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis. New Engl J Med 14 mai. 2020;382(20):1906\u201315. https:\/\/doi.org\/10.1056\/NEJMoa1915254.","journal-title":"New Engl J Med 14 mai"},{"issue":"2","key":"4443_CR52","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/1471-0528.15870","volume":"127","author":"J Van De Wijgert","year":"2020","unstructured":"Van De Wijgert J, Verwijs M. Lactobacilli-containing vaginal probiotics to cure or prevent bacterial or fungal vaginal dysbiosis: a systematic review and recommendations for future trial designs. BJOG janv. 2020;127(2):287\u201399. https:\/\/doi.org\/10.1111\/1471-0528.15870.","journal-title":"BJOG janv"},{"issue":"03","key":"4443_CR53","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4236\/ojog.2015.53024","volume":"05","author":"C Neut","year":"2015","unstructured":"Neut C, Verri\u00e8re F, Nelis HJ, Coenye T. Topical Treatment of Infectious Vaginitis: Effects of Antibiotic, Antifungal and Antiseptic Drugs on the Growth of Normal Vaginal Lactobacillus Strains. OJOG. 2015;05(03):173\u201380. https:\/\/doi.org\/10.4236\/ojog.2015.53024.","journal-title":"OJOG"},{"issue":"2","key":"4443_CR54","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3390\/nu12020419","volume":"12","author":"A Barrientos-Dur\u00e1n","year":"2020","unstructured":"Barrientos-Dur\u00e1n A, Fuentes-L\u00f3pez A, De Salazar A, Plaza-D\u00edaz J, Garc\u00eda F. Reviewing the Composition of Vaginal Microbiota: Inclusion of Nutrition and Probiotic Factors in the Maintenance of Eubiosis. Nutrients 6 f\u00e9vr. 2020;12(2):419. https:\/\/doi.org\/10.3390\/nu12020419.","journal-title":"Nutrients 6 f\u00e9vr"},{"issue":"3","key":"4443_CR55","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1177\/1745505717731011","volume":"13","author":"Y Chen","year":"2017","unstructured":"Chen Y, Bruning E, Rubino J, Eder SE. Role of female intimate hygiene in vulvovaginal health: Global hygiene practices and product usage. Womens Health (Lond Engl) d\u00e9c. 2017;13(3):58\u201367. https:\/\/doi.org\/10.1177\/1745505717731011.","journal-title":"Womens Health (Lond Engl) d\u00e9c"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-026-04443-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-026-04443-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-026-04443-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:38:56Z","timestamp":1781645936000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12905-026-04443-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4443"],"URL":"https:\/\/doi.org\/10.1186\/s12905-026-04443-w","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"17 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Participation in the study was entirely voluntary. Each patient received counseling during which the study objectives and procedures were fully explained. Participants were ensured full understanding of the information provided, emphasizing their right to withdraw at any time without consequence. Patients were reassured that refusal to participate or withdrawal of consent during the study would in no way affect the quality of care they received. This monocentric, prospective, single-arm and observational study was conducted in real-life conditions. All patients received the NNP treatment as part of routine medical care which was prescribed within its approved marketing authorization and established clinical use. No additional diagnostic or therapeutic procedures were performed for research purposes. All participants provided informed consent prior to inclusion, and collected data were anonymized before analysis. The study was conducted in accordance with the ethical principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Profs. C.A.T.C. and M.M.N. are scientific consultants for Laboratoire Innotech International. J.E., B.Q.S., C.P.J.T. and F.C. are employees of Laboratoire Innotech International.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"260"}}